Biogen (BIIB) Q3 2026 Earnings Call Transcript
On its third-quarter 2026 earnings call, Biogen reported that growth portfolio revenue rose 49% and now accounts for 63% of its core pharma sales.
fool.com ·
24/7
-
-over selected period
-since US close
Price differences before fees and execution costs. Compare prices
On its third-quarter 2026 earnings call, Biogen reported that growth portfolio revenue rose 49% and now accounts for 63% of its core pharma sales.
fool.com ·